by Teresa Carroll | News and Updates
The sponsor of the study is NMD Pharma A/S. If you’re living with Charcot-Marie-Tooth (CMT) disease, specifically CMT1 or CMT2 subtypes you may be eligible to participate in an exciting new clinical trial. NMD Pharma, a biotechnology company, has received approval... by Teresa Carroll | News and Updates, Research
New Physical Exercise study published in November, 2024 issue of the Journal of the Peripheral Nervous System The results of a TIN-sponsored study to determine the effects of exercise on the progression of CMT1X, using a mouse model of CMT1X, was first published as... by Teresa Carroll | News and Updates
For Steve O’Donnell, founder of Therapies for Inherited Neuropathies, those are words to live by. He calls them his life’s slogan. The slogan helps him self-motivate to spread awareness of Charcot Marie Tooth disease and to raise money for CMT research. It’s guided... by Teresa Carroll | Physical Therapy
Whether you call it physical therapy or physiotherapy (PT), many of us suffering from an inherited neuropathy like Charcot Marie Tooth (CMT) have had to seek that kind of help for injury, or to help us restore and/or maintain physical functionality while fighting this... by Teresa Carroll | Physical Therapy
“Helping those with CMT remain physically able as we work to find a cure!” Like many of us living with Charcot Marie Tooth Disease (CMT) finding ways to overcome our set of unique challenges in order to stay healthier and remain as physically able as possible is a... 
